Reproductive Medicine Centre, Department of Obstetrics and Gynaecology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Anhui Province Key Laboratory of Reproductive Health and Genetics, Anhui Medical University, Hefei, China.
Reproductive Medicine Centre, Department of Obstetrics and Gynaecology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Reprod Biomed Online. 2024 Aug;49(2):103912. doi: 10.1016/j.rbmo.2024.103912. Epub 2024 Feb 24.
What are the metabolic characteristics of follicular fluid in patients with ovarian endometriosis undergoing IVF?
This was an exploratory cohort study on endometriosis. In total, 19 infertile patients with ovarian endometriosis diagnosed by laparoscopy, and 23 controls matched in terms of age and body mass index (women with infertility due to male or tubal factors) were enrolled in this study. All patients underwent IVF treatment with a gonadotrophin-releasing hormone antagonist protocol, and follicular fluid was collected at oocyte retrieval. The metabolomics of follicular fluid samples was analysed using an ultra-high-performance liquid chromatography Orbitrap Exploris mass spectrometer (UHPLC-OE-MS). The best combination of biomarkers was selected by performing stepwise logistic regression analysis with backward elimination.
Fifteen metabolites were identified as biomarkers associated with endometriosis. A final model containing 8-hydroxy-2-deoxyguanosine, biotin, n-acetyl-L-methionine and n-methylnicotinamide was constructed. Receiver operating characteristic analysis confirmed the value of these parameters in diagnosing endometriosis, with sensitivity of 94.7% and specificity of 95.7%. Enrichment analysis via the Kyoto Encyclopedia of Genes and Genome showed that 15 metabolites were enriched in eight metabolic pathways.
Metabolomics based on UHPLC-OE-MS effectively characterized the metabolomics analysis of follicular fluid in patients with ovarian endometriosis. These findings may provide a new basis for better understanding of how diseases progress, and for the discovery of new biomarkers.
接受体外受精的卵巢子宫内膜异位症患者卵泡液的代谢特征是什么?
这是一项关于子宫内膜异位症的探索性队列研究。共有 19 名经腹腔镜诊断为卵巢子宫内膜异位症的不孕患者和 23 名年龄和体重指数匹配的对照者(因男性或输卵管因素导致不孕的妇女)纳入本研究。所有患者均采用促性腺激素释放激素拮抗剂方案进行体外受精治疗,并在取卵时收集卵泡液。采用超高效液相色谱-轨道阱质谱联用仪(UHPLC-OE-MS)分析卵泡液样本的代谢组学。通过逐步逻辑回归分析和向后消除法选择最佳的生物标志物组合。
确定了 15 种代谢物作为与子宫内膜异位症相关的生物标志物。构建了一个包含 8-羟基-2-脱氧鸟苷、生物素、N-乙酰-L-蛋氨酸和 N-甲基烟酰胺的最终模型。受试者工作特征分析证实了这些参数在诊断子宫内膜异位症方面的价值,敏感性为 94.7%,特异性为 95.7%。京都基因与基因组百科全书的富集分析表明,15 种代谢物富集在 8 条代谢途径中。
基于 UHPLC-OE-MS 的代谢组学有效地对卵巢子宫内膜异位症患者卵泡液的代谢组学分析进行了特征描述。这些发现可能为更好地了解疾病进展提供新的依据,并为发现新的生物标志物提供新的依据。